Revenue
2021
2022
2023
2024
2025
2026
CytoDyn Inc. (CYDY)
Price$0.1993Cached quote
Net income
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2011
2013
2014
2015
2016
2017
2018
2019
2020
2021
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $266,000 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | $0 | −$20.6M | $213,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | 80.08% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $15.7M | −$16.9M | $7.2M | $2.6M | $27.0M | $53.4M | $52.6M | $42.5M | $38.2M | $20.2M | $13.7M | $15.2M | $4.0M | $619,838 | $530,027 | $480,765 | — | — | — | — | — | — |
| Operating expenses | $23.5M | −$9.7M | $18.1M | $40.6M | $145.6M | $104.6M | $74.6M | $55.9M | $45.9M | $27.3M | $21.2M | $19.6M | $8.1M | $8.0M | $7.5M | $3.7M | — | — | — | — | — | — |
| Operating income | −$38.6M | $9.7M | −$18.1M | −$40.6M | −$145.4M | −$104.6M | −$74.6M | −$55.9M | −$45.9M | −$27.3M | −$21.2M | −$19.6M | −$8.1M | −$8.0M | −$7.5M | −$3.7M | — | — | — | — | — | — |
| Operating margin | — | — | — | — | −54,663.16% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$38.6M | $9.7M | −$18.0M | −$40.4M | −$144.6M | −$102.8M | −$72.6M | −$54.6M | −$45.6M | −$27.0M | −$20.8M | −$19.2M | −$7.8M | −$7.8M | −$7.5M | −$3.7M | — | — | — | — | — | — |
| EBITDA margin | — | — | — | — | −54,369.55% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$42.7M | $3.7M | −$49.8M | −$79.8M | −$210.8M | −$176.5M | −$139.9M | −$56.2M | −$50.1M | −$25.8M | −$25.7M | −$25.1M | −$12.4M | −$9.6M | −$7.5M | −$3.7M | −$3.4M | −$1.3M | −$1.2M | −$2.6M | −$2.1M | −$777,083 |
| Net profit margin | — | — | — | — | −79,255.64% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$0.03 | $0.00 | -$0.05 | -$0.10 | -$0.31 | -$0.30 | -$0.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$0.03 | $0.00 | -$0.05 | -$0.10 | -$0.31 | -$0.30 | -$0.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
DIVERSIFIED TRUST CO | 45.79K |
Williams Jones Wealth Management, LLC. | 45K |
Next Capital Management LLC | 25K |
HORIZON FINANCIAL SERVICES, LLC | 18.2K |
Ancora Advisors LLC | 9.49K |
CAZ INVESTMENTS LP | 8K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data